Literature DB >> 35320537

Evaluating the Role of Galectins in Clathrin-Independent Endocytosis.

Mohit P Mathew1, Julie G Donaldson2, John A Hanover3.   

Abstract

Galectin-3 is a chimeric galectin involved in diverse intracellular and extracellular functions. Galectin-3 is synthesized in the cytoplasm and then released extracellularly by a poorly understood non-canonical secretion mechanism. As a result, it can play important roles both inside and outside the cell. One important extracellular role of galectin-3 is in modulating clathrin-independent endocytosis (CIE), a form of cellular internalization that is still not well understood. CIE, unlike clathrin-mediated endocytosis, has neither defined signaling sequences nor cytoplasmic machinery. As a result, extracellular interactions like the galectin-glycan interactions are thought to directly drive changes in CIE. This chapter discusses the methods designed to study the role of galectin-glycan interactions in CIE, which have provided us with insight into the functions of galectin-3 and cell surface glycans during CIE cargo internalization. These methods include media supplementation for metabolic glycoengineering, antibody internalization assays, lectin panels to assay changes in glycan patterns, exogenous galectin-3 supplementation, galectin-3 secretion assays, and in vitro assays to monitor the effect of galectins on CIE.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibody internalization assay; Clathrin-independent endocytosis; Galectin-3; Galectin-3 secretion assay

Mesh:

Substances:

Year:  2022        PMID: 35320537     DOI: 10.1007/978-1-0716-2055-7_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

1.  Concentrations of galectin-3 in the sera of normal controls and cancer patients.

Authors:  I Iurisci; N Tinari; C Natoli; D Angelucci; E Cianchetti; S Iacobelli
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

Review 2.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 3.  Intracellular functions of galectins.

Authors:  Fu-Tong Liu; Ronald J Patterson; John L Wang
Journal:  Biochim Biophys Acta       Date:  2002-09-19

Review 4.  The galectin lattice at a glance.

Authors:  Ivan R Nabi; Jay Shankar; James W Dennis
Journal:  J Cell Sci       Date:  2015-06-19       Impact factor: 5.285

5.  Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.

Authors:  Carla Iacobini; Claudia Blasetti Fantauzzi; Rossella Bedini; Raffaella Pecci; Armando Bartolazzi; Bruno Amadio; Carlo Pesce; Giuseppe Pugliese; Stefano Menini
Journal:  Metabolism       Date:  2018-02-09       Impact factor: 8.694

6.  Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells.

Authors:  V Furtak; F Hatcher; J Ochieng
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

7.  Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.

Authors:  Inder S Anand; Thomas S Rector; Michael Kuskowski; Aram Adourian; Pieter Muntendam; Jay N Cohn
Journal:  Eur J Heart Fail       Date:  2013-01-04       Impact factor: 15.534

8.  Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.

Authors:  Ha-Jeong Kim; In-Gu Do; Hye-Kyung Jeon; Young Jae Cho; Young Ae Park; Jung-Joo Choi; Chang Ohk Sung; Yoo-Young Lee; Chel Hun Choi; Tae-Joong Kim; Byoung-Gie Kim; Jeong-Won Lee; Duk-Soo Bae
Journal:  Hum Pathol       Date:  2012-08-30       Impact factor: 3.466

Review 9.  Extracellular functions of galectin-3.

Authors:  Josiah Ochieng; Vyacheslav Furtak; Pavel Lukyanov
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.

Authors:  R S Bresalier; N Mazurek; L R Sternberg; J C Byrd; C K Yunker; P Nangia-Makker; A Raz
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.